Docetaxel/Cyclophosphamide-Induced Phototherapy Recall

Area of Science:

• Dermatology
• Oncology
• Pharmacology

Background:

• Phototherapy recall is an uncommon inflammatory reaction potentially triggered by various medications, including chemotherapy agents.
• Cyclophosphamide and docetaxel are frequently utilized in treating diverse malignancies.
• The exact mechanisms underlying phototherapy recall remain incompletely elucidated.

Observation:

• This report details a case of phototherapy recall dermatitis.
• The reaction manifested years after the initial ultraviolet (UV) light exposure.
• The patient had been treated with cyclophosphamide and docetaxel for their malignancy.

Findings:

• This is the first documented instance of phototherapy recall dermatitis occurring years post-UV exposure, induced by cyclophosphamide and docetaxel.
• The study underscores the potential for delayed cutaneous adverse reactions to chemotherapy.
• The pathophysiology of this delayed reaction is not fully understood.

Implications:

• Clinicians should maintain awareness of the possibility of phototherapy recall dermatitis, even with remote UV exposure history.
• This emphasizes the need for vigilance regarding potential long-term side effects of common chemotherapeutic agents.
• Understanding such reactions is crucial for patient management and safety in oncology and dermatology.